TTK and hepatocellular carcinoma: A novel TRP score based on four genes (TTK, EPO, SLC7A11, PON1) accurately predicts TACE refractoriness and prognosis in HCC, identifying tumors with immunosuppressive phenotypes and guiding therapy decisions, including ICIs and sorafenib